In a previous study, researchers observed that liver cell count reduction after the onset of liver disease promoted an upregulation of c-Met and/or HGF expression, which in turn stimulated hepatocyte proliferation, regeneration, and survival, ultimately leading to a delay in the development of liver disease. Here, HGF is linked to liver disorder.